drugset / Trial / NCT01676363

Pilot Study of Diflunisal in HIV-infected Adults

NCT01676363

Phase 4 Terminated 8 enrolled University of British Columbia
NaSingle-groupOpen-labelTreatment

Summary

Diflunisal is an anti-inflammatory drug (like ASA or ibuprofen) that has been used as a painkiller for 20 years. Recent research shows that it may have an anti-HIV effect in the laboratory. Approximately 20 HIV-infected adults who are not receiving antiretroviral therapy will be given diflunisal by mouth twice daily for 4 weeks, at a dose that has been shown to be safe when used to treat pain. Subjects will be monitored closely for safety and will have frequent blood tests during the study to see if the drug has any effect on the level of HIV in their blood.

Timeline

Start
2013-03
Primary completion
2016-10-12
Completion
2016-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject diflunisal Small molecule 500 mg Oral